Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of serum adipocytokines with insulin resistance and liver injury in patients with chronic hepatitis C genotype 4.

Journal of clinical gastroenterology - 1 Jan 2000

Khattab Mahmoud Aboelneen, Eslam Mohammed, Aly Mayada M, Shatat Mohammed, Hussen Azaa, Moussa Yossef I, Elsaghir Ghada, Abdalhalim Hesham, Aly Ahmed, Gaber Salwa, Harrison Stephen A

Abstract excerpt

BACKGROUND: Hepatitis C virus (HCV) infection, especially genotypes 1 and 4, is associated with metabolic dysfunction. We investigated the potential role of adipocytokines in HCV-induced insulin resistance (IR) and modulating the progression of liver disease in patients with HCV-4. METHODS: Serum adiponectin, high molecular weight adiponectin, leptin, tumor necrosis factor-α, interluekin-6, homeostasis model for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adipokines
Share to Adiponectin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to fas Receptor

Share to Fatty Liver

Share to Hepatocytes

Share to Leptin

Share to Liver Cirrhosis

Share to Receptors, Adiponectin

Source

Identifiers

PMID: 22664476
DOI: 10.1097/MCG.0b013e318256b68a

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of serum adipocytokines with insulin resistance and liver injury in patients with chronic hepatitis C genotype 4.PMID 22664476Read ↗

Adiponectin inhibits steatotic CD95/Fas up-regulation by hepatocytes: therapeutic implications for hepatitis C.Semantic proximity Read ↗

Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C.Semantic proximity Read ↗

Hepatitis C virus infection: molecular pathways to metabolic syndrome.Semantic proximity Read ↗

Changes in adipocytokines and insulin sensitivity during and after antiviral therapy for hepatitis C genotype 4.Semantic proximity Read ↗

The relationship between serum adiponectin and steatosis in patients with chronic hepatitis C genotype-4.Semantic proximity Read ↗

Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis c virus genotype 1.Semantic proximity Read ↗

Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines.Semantic proximity Read ↗

Association of serum adipocytokines with hepatic steatosis and fibrosis in patients with chronic hepatitis C.Semantic proximity Read ↗

Adipokines and insulin resistance, predictors of response to therapy in Egyptian patients with chronic hepatitis C virus genotype 4.Semantic proximity Read ↗

Hepatic steatosis in genotype 4 chronic hepatitis C patients: implication for therapy.Semantic proximity Read ↗

Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients.Semantic proximity Read ↗

Metabolic alterations and hepatitis C: From bench to bedside.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.